William Comanor and FM Scherer Memo on Pharma Mergers and Innovation

Apr 08 2009
Testimony and Interventions

Professors Comanor and Scherer have submitted a second AAI memo to the FTC calling attention to the potential innovation effects of the pending Pfizer-Wyeth and Merck-Schering Plough mergers and urging the FTC to take into account "not only the consequences of the individual mergers but also their broader systemic effects on pharmaceutical innovation."

 

Read the memo here.